非酒精性脂肪性肝病的发病率及其对代谢负担和死亡的影响:一项20年社区研究
基于美国明尼苏达州奥姆斯特德县1997至2014年社区队列,识别3869例NAFLD患者与15209名对照,随访中位7年。NAFLD发病率从每10万人年62例增至329例,增长5倍;NAFLD患者10年死亡率10.2%高于对照7.6%,且NAFLD是代谢合并症和死亡的独立危险因素。
要点
- NAFLD发病率在20年间增长5倍,18-39岁年轻成人增长最高达7倍。
- NAFLD患者10年死亡率为10.2%,高于对照人群的7.6%(P < 0.0001)。
- NAFLD患者合并0个代谢合并症时死亡风险RR=2.16(95%CI 1.41-3.31),合并1、2、3个时RR分别为1.99、1.75、1.08。
核心结论
- 社区中NAFLD诊断发病率增长5倍,尤其在年轻成人中。
- NAFLD是代谢合并症的结果,也是其前驱因素。
- 新发代谢合并症减弱NAFLD对死亡的影响,并抵消其对心血管疾病的影响。
研究设计与样本
- 利用罗切斯特流行病学项目数据库构建1997至2014年明尼苏达州奥姆斯特德县所有诊断为NAFLD的成人社区队列。
- 识别3869例NAFLD受试者(中位年龄53岁,52%为女性)和15209名年龄、性别匹配(4:1)的普通人群对照。
- 中位随访7年(范围1-20年),计算年发病率,采用多状态模型分析NAFLD对新发代谢合并症、心血管事件和死亡率的影响。
主要发现
- NAFLD发病率从每10万人年62例增至329例,增长5倍;18-39岁年轻成人增长最高达7倍。
- NAFLD患者10年死亡率为10.2%,高于对照的7.6%(P < 0.0001)。
- NAFLD患者合并0、1、2、3个代谢合并症时死亡相对风险分别为RR=2.16(95%CI 1.41-3.31)、1.99(95%CI 1.48-2.66)、1.75(95%CI 1.42-2.14)、1.08(95%CI 0.89-1.30)。
- NAFLD对心血管事件的影响仅在无代谢合并症的受试者中显著(RR=1.96,95%CI 1.35-2.86)。
- NAFLD使预期寿命缩短4年,且更多时间处于高代谢负担状态。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Recent population-based data on nonalcoholic fatty liver disease (NAFLD) epidemiology in general, and incidence in particular, are lacking. We examined trends in NAFLD incidence in a U.S. community and the impact of NAFLD on incident metabolic comorbidities (MCs), cardiovascular (CV) events, and mortality. A community cohort of all adults diagnosed with NAFLD in Olmsted County, Minnesota, between 1997 and 2014 was constructed using the Rochester Epidemiology Project database. The yearly incidence rate were calculated. The impact of NAFLD on incident MCs, CV events, and mortality was studied using a multistate model, with a 4:1 age- and sex-matched general population as a reference. We identified 3,869 NAFLD subjects (median age, 53; 52% women) and 15,209 controls; median follow-up was 7 (1-20) years. NAFLD incidence increased 5-fold, from 62 to 329 in 100,000 person-years. The increase was highest (7-fold) in young adults, aged 18-39 years. The 10-year mortality was higher in NAFLD subjects (10.2%) than controls (7.6%; P < 0.0001). NAFLD was an independent risk factor for incident MCs and death. Mortality risk decreased as the number of incident MCs increased: relative risk (RR) = 2.16 (95% confidence [CI], 1.41-3.31), 1.99 (95% CI, 1.48-2.66), 1.75 (95% CI, 1.42-2.14), and 1.08 (95% CI, 0.89-1.30) when 0, 1, 2, or 3 MCs were present, respectively. The NAFLD impact on CV events was significant only in subjects without MCs (RR = 1.96; 95% CI = 1.35-2.86). NAFLD reduced life expectancy by 4 years, with more time spent in high metabolic burden. CONCLUSION: Incidence of NAFLD diagnosis in the community has increased 5-fold, particularly in young adults. NAFLD is a consequence, but also a precursor of MC. Incident MC attenuates the impact of NAFLD on death and annuls its impact on CV disease. (Hepatology 2018;67:1726-1736).
引用
- Allen AM, Therneau TM, Larson JJ, et al. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study. Hepatology. 2018. PMID: 28941364. doi:10.1002/hep.29546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。